As the Deputy Director of Communications for Leaps by Bayer, I surveyed a brain trust of scientists, investors, and CEOs to learn which areas of biotech they are most eagerly watching this year.
2022 saw some incredible scientific and technological breakthroughs, as well as some major medical breakthroughs — and 2023 is poised to follow up with more paradigm-shifting advances in the making. As the Deputy Director of Communications for Leaps by Bayer, I surveyed a brain trust of scientists, investors, and CEOs to learn which areas of biotech they are most eagerly watching this year. Here’s what they said.